Share

August 20, 2019; 93 (8) Corrections

INTREPAD

A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease

First published August 19, 2019, DOI: https://doi.org/10.1212/WNL.0000000000007919
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
109

Share

See original article:

In the article “INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease" by Meyer et al.,1 first published online April 5, 2019, Dr. Lafaille-Magnan’s name should appear in the author list as Marie-Elyse Lafaille-Magnan. The authors regret the error.

Reference

  1. 1.↵
    1. Meyer PF,
    2. Tremblay-Mercier J,
    3. Leoutsakos J, et al.
    INTREPAD: a randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease. Neurology 2019;92:e2070--e2080.
    OpenUrlAbstract/FREE Full Text
View Abstract

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Alert Me